Low baseline IFN-γ response could predict hospitalization in COVID-19 patients
The SARS-CoV-2 infection has spread rapidly around the world causing millions of deaths. Several treatments can reduce mortality and hospitalization. However, their efficacy depends on the choice of the molecule and the precise timing of its administration to ensure viral clearance and avoid a delet...
Main Authors: | Marion Cremoni, Jonathan Allouche, Daisy Graça, Kevin Zorzi, Céline Fernandez, Maxime Teisseyre, Sylvia Benzaken, Caroline Ruetsch-Chelli, Vincent L. M. Esnault, Jean Dellamonica, Michel Carles, Jérôme Barrière, Michel Ticchioni, Vesna Brglez, Barbara Seitz-Polski |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.953502/full |
Similar Items
-
Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy
by: Maxime Teisseyre, et al.
Published: (2022-05-01) -
Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients
by: Caroline Ruetsch, et al.
Published: (2021-01-01) -
Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and Relapses
by: Marion Cremoni, et al.
Published: (2020-11-01) -
Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses
by: Matthieu Buscot, et al.
Published: (2023-03-01) -
Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy
by: Maxime Teisseyre, et al.
Published: (2021-04-01)